As shown in Table 4, high CST2 mRNA levels showed significantly worse prognosis in male and female, tumor stage III and IV, Lauren classification as intestinal and diffuse, poorly differentiated tumor, surgery alone as treatment, and positive and negative HER2 status in the KM plotter online database. This evidence concerns the gene CST2 and neoplasm.